Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Bacteria

ABSTRACT: Whole genome sequencing of antimicrobial-resistant bacteria isolated from environment including aquatic animals and plants in Japan

PROVIDER: PRJDB11802 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	BPNA01.dat.gz	Other
	BPNA01.fasta.gz	Fasta.gz
	BPNA01.master.dat	Other
	BPNB01.dat.gz	Other

Items per page:

1 - 5 of 244

Similar Datasets

Bacteria

Project description:Complete genome sequencing of antimicrobial-resistant bacteria isolated from environment including aquatic animals and plants in Japan

| PRJDB13144 | ENA

Bacteria

Project description:Whole genome sequencing of antimicrobial-resistant bacteria isolated from aquatic animals, plants, and environment in Asia

| PRJDB10427 | ENA

Bacteria

Project description:Whole genome sequencing of antimicrobial-resistant bacteria including CPE isolated from hospitalized patients in Japan

| PRJDB12730 | ENA

Escherichia

Project description:Genomic analysis of antimicrobial resistant bacteria isolated in the environment in Japan

| PRJDB14133 | ENA

Antibiotic Resistance Profile and Genomic Characteristics of Multidrug-Resistant Bacteria from the Sludge of a Pharmaceutical Wastewater Treatment Plant

Project description:Incomplete antibiotic removal in pharmaceutical wastewater treatment plants (PWWTPs) could lead to the development and spread of antibiotic-resistant bacteria (ARBs) and genes (ARGs) in the environment, posing a growing public health threat. In this study, two multiantibiotic-resistant bacteria, Ochrobactrum intermedium (N1) and Stenotrophomonas acidaminiphila (N2), were isolated from the sludge of a PWWTP in Guangzhou, China. The N1 strain was highly resistant to ampicillin, cefazolin, chloramphenicol, tetracycline, and norfloxacin, while the N2 strain exhibited high resistance to ampicillin, chloramphenicol, and cefazolin. Whole-genome sequencing revealed that N1 and N2 had genome sizes of 0.52 Mb and 0.37 Mb, respectively, and harbored 33 and 24 ARGs, respectively. The main resistance mechanism in the identified ARGs included efflux pumps, enzymatic degradation, and target bypass, with the N1 strain possessing more multidrug-resistant efflux pumps than the N2 strain (22 vs 12). This also accounts for the broader resistance spectrum of N1 than of N2 in antimicrobial susceptibility tests. Additionally, both genomes contain numerous mobile genetic elements (89 and 21 genes, respectively) and virulence factors (276 and 250 factors, respectively), suggesting their potential for horizontal transfer and pathogenicity. Overall, this research provides insights into the potential risks posed by ARBs in pharmaceutical wastewater and emphasizes the need for further studies on their impact and mitigation strategies.

2024-10-20 | E-MTAB-14497 | biostudies-arrayexpress

Bacteria

Project description:Study on prevalence of antimicrobial-resistant bacteria isolated from livestock, pens environments, and livestock workers

| PRJNA485681 | ENA

Collateral sensitivity of antibiotic resistant bacteria to antimicrobial peptides

Project description:Cationic antimicrobial peptides (CAPs) are promising novel alternatives to conventional antibacterial agents, but the overlap in resistance mechanisms between small-molecule antibiotics and CAPs is unknown. Does evolution of antibiotic resistance decrease (cross-resistance) or increase (collateral sensitivity) susceptibility to CAPs? We systematically addressed this issue by studying the susceptibilities of a comprehensive set of antibiotic resistant Escherichia coli strains towards 24 antimicrobial peptides. Strikingly, antibiotic resistant bacteria frequently showed collateral sensitivity to CAPs, while cross-resistance was relatively rare. We identified clinically relevant multidrug resistance mutations that simultaneously elevate susceptibility to certain CAPs. Transcriptome and chemogenomic analysis revealed that such mutations frequently alter the lipopolysaccharide composition of the outer cell membrane and thereby increase the killing efficiency of membrane-interacting antimicrobial peptides. Furthermore, we identified CAP-antibiotic combinations that rescue the activity of existing antibiotics and slow down the evolution of resistance to antibiotics. Our work provides a proof of principle for the development of peptide based antibiotic adjuvants that enhance antibiotic action and block evolution of resistance.

2018-03-29 | GSE96706 | GEO

Bacteria

Project description:Nontuberculous mycobacteria isolated from soil in a swine farm in Japan

| PRJNA477702 | ENA

Escherichia coli

Project description:Escherichia coli strains in the aquatic environment in Shiga Prefecture, Japan

| PRJNA799078 | ENA

Escherichia coli

Project description:Multidrug-resistant Escherichia coli isolated from animals

| PRJNA589224 | ENA